This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Medical University of Innsbruck, Vichem Chemie Kutató Kft., Vichem Chemie Kutato Korlatolt Felelossegu Tarsasag. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 3 
1 out of 1 Years Active: 2018-2021
Title: Innovator Csaba Szántai-Kis: A Pioneer in Pharmaceutical Discoveries
Introduction
Csaba Szántai-Kis, an inventive mind based in Budapest, Hungary, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he has pioneered innovative compounds that aim to address critical health challenges, particularly in cancer treatment and bacterial infections.
Latest Patents
Szántai-Kis is particularly well-known for his latest patents, which include the groundbreaking discovery of 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones. This compound serves as a potent inhibitor of cyclin-dependent kinases (CDKs) and is essential for the prophylaxis and treatment of cancer and other proliferative diseases. Additionally, he has developed styryl quinazoline derivatives, identified as promising drug candidates for conditions related to hematopoiesis dysfunctions and various forms of leukemia. These derivatives also exhibit antibacterial properties, offering new avenues for combating bacterial infections.
Career Highlights
Throughout his career, Csaba has worked with esteemed institutions such as the Medical University of Innsbruck and Vichem Chemie Kutató Korlátolt Felelősségű Társaság. His academic and professional endeavors have equipped him with the expertise necessary to excel in drug development and innovative research.
Collaborations
Csaba Szántai-Kis’s journey has also been marked by fruitful collaborations. Notable colleagues such as Péter Bánhegyi and Winfried Wunderlech have partnered with him to advance their shared goals in pharmaceutical research, driving the success of their projects through teamwork.
Conclusion
In summary, Csaba Szántai-Kis is a remarkable inventor whose work is having a lasting impact on the pharmaceutical landscape. His innovative patents not only highlight his expertise but also signify vital steps towards developing effective treatments for serious health issues. As he continues to push the boundaries of scientific discovery, Szántai-Kis remains a pivotal figure in the realm of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile